SESN3 and metabolic dysfunction-associated steatohepatitis: Besides, SESN3 has been demonstrated to be in involved TGFβ-Smads signaling by inhibiting the SMADs family at both protein and mRNA expression levels, thus protecting against diet-induced non-alcoholic steatohepatitis (NASH) in mice [24].